share_log
Moomoo 24/7 ·  Apr 15 08:50
Organovo Shares Are Trading Higher After the Company Announced Phase 2 Results for FXR314. Study Results Demonstrated Statistically Significant Reduction in Liver Fat Content From Baseline in Patients Receiving FXR314 Compared to Placebo
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment